Clinical Trial Update: A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

View source ↗

Summary

A terminated pilot biomarker study evaluating alpha-synuclein aggregates across biofluid reservoirs in synucleinopathies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Normal Pressure Hydrocephalus
• Parkinson Disease
• Rem Sleep Behavior Disorder

Snippet

Sponsor: Stony Brook University | Conditions: Parkinson Disease, Multiple System Atrophy | Status: TERMINATED